|
PIBF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.058400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.012800E-01 |
| Normal-vs-Stage2 |
1.109640E-02 |
| Normal-vs-Stage3 |
9.382900E-03 |
| Normal-vs-Stage4 |
3.520100E-03 |
| Stage1-vs-Stage2 |
6.719500E-02 |
| Stage1-vs-Stage3 |
5.568500E-02 |
| Stage1-vs-Stage4 |
4.157800E-02 |
| Stage2-vs-Stage3 |
8.733400E-01 |
| Stage2-vs-Stage4 |
9.175800E-01 |
| Stage3-vs-Stage4 |
7.615000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.778700E-03 |
| Normal-vs-AfricanAmerican |
4.632600E-01 |
| Normal-vs-Asian |
1.670820E-01 |
| Caucasian-vs-AfricanAmerican |
4.389700E-02 |
| Caucasian-vs-Asian |
4.028000E-01 |
| AfricanAmerican-vs-Asian |
1.401390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.355230E-01 |
| Normal-vs-Female |
1.574430E-02 |
| Male-vs-Female |
6.032200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.159200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.563800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.206700E-04 |
| Normal-vs-Age(81-100Yrs) |
9.875600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.850750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.062400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.447700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.330500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.188600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.271000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.755400E-04 |
| Classical-VS-Follicular |
4.378000E-01 |
| Classical-VS-Other |
8.943600E-01 |
| Classical-VS-Normal |
9.213800E-02 |
| Tall-VS-Follicular |
2.444200E-03 |
| Tall-VS-Other |
1.219960E-01 |
| Tall-VS-Normal |
6.42189999999765E-05 |
| Follicular-VS-Other |
7.468400E-01 |
| Follicular-VS-Normal |
5.875600E-01 |
| Other-VS-Normal |
3.713200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.258200E-02 |
| Normal-vs-N1 |
1.335010E-01 |
| N0-vs-N1 |
8.298600E-01 |
|
|
